These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8494368)

  • 1. Pharmacokinetics and bactericidal activities of one 800-milligram dose versus two 400-milligram doses of intravenously administered pefloxacin in healthy volunteers.
    Petitjean O; Pangon B; Brion N; Tod M; Chaplain C; Le Gros V; Louchahi K; Allouch P
    Antimicrob Agents Chemother; 1993 Apr; 37(4):737-40. PubMed ID: 8494368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
    Van der Auwera P; Klastersky J; Lieppe S; Husson M; Lauzon D; Lopez AP
    Antimicrob Agents Chemother; 1986 Feb; 29(2):230-4. PubMed ID: 3087276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteers.
    Naber KG; Theuretzbacher U; Kinzig M; Savov O; Sörgel F
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1659-65. PubMed ID: 9661000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of pefloxacin in goats after intravenous or oral administration.
    Malik JK; Rao GS; Ramesh S; Muruganandan S; Tripathi HC; Shukla DC
    Vet Res Commun; 2002 Feb; 26(2):141-9. PubMed ID: 11922483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin.
    Dreetz M; Hamacher J; Eller J; Borner K; Koeppe P; Schaberg T; Lode H
    Antimicrob Agents Chemother; 1996 Jan; 40(1):105-9. PubMed ID: 8787889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of pefloxacin and amikacin administered simultaneously to intensive care patients.
    Sultan E; Richard C; Pezzano M; Auzepy P; Singlas E
    Eur J Clin Pharmacol; 1988; 34(6):637-43. PubMed ID: 3169115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tissue distribution of intravenous pefloxacin for antibiotic prophylaxis in biliary surgery.
    Gascón AR; Campo E; Olea E; Hernández RM; Calvo B; Errasti J; Pedraz JL
    Biopharm Drug Dispos; 2002 Oct; 23(7):293-300. PubMed ID: 12355580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vivo bactericidal effect of ciprofloxacin, ofloxacin and pefloxacin against Staphylococcus aureus].
    Tronel H; Voiriot P; Weber M; Dopff C; Dewachter P; Phelisse F; Dureux JB
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):578-81. PubMed ID: 2797882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.
    Paulfeuerborn W; Müller HJ; Borner K; Koeppe P; Lode H
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1835-41. PubMed ID: 8239592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose.
    Hofbauer H; Naber KG; Kinzig-Schippers M; Sörgel F; Rustige-Wiedemann C; Wiedemann B; Reiz A; Kresken M
    Infection; 1997; 25(2):121-6. PubMed ID: 9108190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report: pharmacokinetic and drug interaction studies of pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan.
    Gauhar S; Ali SA; Naqvi SB; Shoaib MH
    Pak J Pharm Sci; 2014 Mar; 27(2):389-95. PubMed ID: 24577931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Wydra S; Onda H; Kinzig-Schippers M; Sörgel F; Naber KG
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3789-94. PubMed ID: 14638484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levofloxacin pharmacokinetics and serum bactericidal activities against five enterobacterial species.
    Geerdes-Fenge HF; Wiedersich A; Wagner S; Lehr KH; Koeppe P; Lode H
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3478-80. PubMed ID: 11083664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of serum teicoplanin concentrations following daily or alternate daily dosing in healthy adults.
    Rouveix B; Jehl F; Drugeon H; Brumpt I; Caulin E
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2394-9. PubMed ID: 15215086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum pharmacokinetics and in vitro antibacterial activity of pefloxacin, ofloxacin and ciprofloxacin].
    Nordmann P; Jarlier V
    Presse Med; 1990 Sep 1-8; 19(28):1321-5. PubMed ID: 2145562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers.
    Leighton A; Gottlieb AB; Dorr MB; Jabes D; Mosconi G; VanSaders C; Mroszczak EJ; Campbell KC; Kelly E
    Antimicrob Agents Chemother; 2004 Mar; 48(3):940-5. PubMed ID: 14982787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis.
    Juvin ME; Potel G; Caillon J; Xiong YQ; Bugnon D; Le Conte P; Baron DI; Drugeon HB
    Antimicrob Agents Chemother; 1994 Apr; 38(4):883-5. PubMed ID: 8031065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal effect of pefloxacin and fosfomycin against Pseudomonas aeruginosa in a rabbit endocarditis model with pharmacokinetics of pefloxacin in humans simulated in vivo.
    Bugnon D; Potel G; Xiong YQ; Caillon J; Navas D; Gras C; Kergueris MF; Le Conte P; Jehl F; Baron D; Drugeon H
    Eur J Clin Microbiol Infect Dis; 1997 Aug; 16(8):575-80. PubMed ID: 9323468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections.
    James JK; Palmer SM; Levine DP; Rybak MJ
    Antimicrob Agents Chemother; 1996 Mar; 40(3):696-700. PubMed ID: 8851595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activities of pefloxacin and ciprofloxacin in the treatment of chronic respiratory tract infections.
    Scaglione F; Scamazzo F; Arcidiacono MM; Cogo R; Monzani GP; Fraschini F
    J Chemother; 1995 Apr; 7(2):140-5. PubMed ID: 7666121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.